Development of new MDR-tuberculosis drugs:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Science Publisher/Nova Biomedical
c2010
|
| Schriftenreihe: | Pharmacology-research, safety testing, and regulation series
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs |
| Beschreibung: | 1 Online-Ressource (xii, 98 p.) |
| ISBN: | 1616682337 161668478X 9781616682330 9781616684785 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043066650 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 1616682337 |9 1-61668-233-7 | ||
| 020 | |a 161668478X |c electronic bk. |9 1-61668-478-X | ||
| 020 | |a 9781616682330 |9 978-1-61668-233-0 | ||
| 020 | |a 9781616684785 |c electronic bk. |9 978-1-61668-478-5 | ||
| 035 | |a (OCoLC)682621157 | ||
| 035 | |a (DE-599)BVBBV043066650 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615.5/8 |2 22 | |
| 100 | 1 | |a Vinšová, Jarmila |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Development of new MDR-tuberculosis drugs |c Jarmila Vinšová and Martin Krátký |
| 264 | 1 | |a New York |b Nova Science Publisher/Nova Biomedical |c c2010 | |
| 300 | |a 1 Online-Ressource (xii, 98 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs | ||
| 650 | 7 | |a MEDICAL / Chemotherapy |2 bisacsh | |
| 650 | 4 | |a Tuberculosis, Multidrug-Resistant / drug therapy | |
| 650 | 4 | |a Drug Discovery | |
| 650 | 4 | |a Drug Resistance, Multiple / drug effects | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Antitubercular agents | |
| 650 | 4 | |a Multidrug-resistant tuberculosis |x Chemotherapy | |
| 700 | 1 | |a Krátký, Martin |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028490842 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175446190850048 |
|---|---|
| any_adam_object | |
| author | Vinšová, Jarmila |
| author_facet | Vinšová, Jarmila |
| author_role | aut |
| author_sort | Vinšová, Jarmila |
| author_variant | j v jv |
| building | Verbundindex |
| bvnumber | BV043066650 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)682621157 (DE-599)BVBBV043066650 |
| dewey-full | 615.5/8 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.5/8 |
| dewey-search | 615.5/8 |
| dewey-sort | 3615.5 18 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02092nmm a2200481zc 4500</leader><controlfield tag="001">BV043066650</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1616682337</subfield><subfield code="9">1-61668-233-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">161668478X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-61668-478-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781616682330</subfield><subfield code="9">978-1-61668-233-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781616684785</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-61668-478-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)682621157</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043066650</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.5/8</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Vinšová, Jarmila</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of new MDR-tuberculosis drugs</subfield><subfield code="c">Jarmila Vinšová and Martin Krátký</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publisher/Nova Biomedical</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xii, 98 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Chemotherapy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis, Multidrug-Resistant / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Multiple / drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antitubercular agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multidrug-resistant tuberculosis</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krátký, Martin</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028490842</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043066650 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:25Z |
| institution | BVB |
| isbn | 1616682337 161668478X 9781616682330 9781616684785 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028490842 |
| oclc_num | 682621157 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xii, 98 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Science Publisher/Nova Biomedical |
| record_format | marc |
| series2 | Pharmacology-research, safety testing, and regulation series |
| spelling | Vinšová, Jarmila Verfasser aut Development of new MDR-tuberculosis drugs Jarmila Vinšová and Martin Krátký New York Nova Science Publisher/Nova Biomedical c2010 1 Online-Ressource (xii, 98 p.) txt rdacontent c rdamedia cr rdacarrier Pharmacology-research, safety testing, and regulation series Includes bibliographical references and index Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs MEDICAL / Chemotherapy bisacsh Tuberculosis, Multidrug-Resistant / drug therapy Drug Discovery Drug Resistance, Multiple / drug effects Medizin Antitubercular agents Multidrug-resistant tuberculosis Chemotherapy Krátký, Martin Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571 Aggregator Volltext |
| spellingShingle | Vinšová, Jarmila Development of new MDR-tuberculosis drugs MEDICAL / Chemotherapy bisacsh Tuberculosis, Multidrug-Resistant / drug therapy Drug Discovery Drug Resistance, Multiple / drug effects Medizin Antitubercular agents Multidrug-resistant tuberculosis Chemotherapy |
| title | Development of new MDR-tuberculosis drugs |
| title_auth | Development of new MDR-tuberculosis drugs |
| title_exact_search | Development of new MDR-tuberculosis drugs |
| title_full | Development of new MDR-tuberculosis drugs Jarmila Vinšová and Martin Krátký |
| title_fullStr | Development of new MDR-tuberculosis drugs Jarmila Vinšová and Martin Krátký |
| title_full_unstemmed | Development of new MDR-tuberculosis drugs Jarmila Vinšová and Martin Krátký |
| title_short | Development of new MDR-tuberculosis drugs |
| title_sort | development of new mdr tuberculosis drugs |
| topic | MEDICAL / Chemotherapy bisacsh Tuberculosis, Multidrug-Resistant / drug therapy Drug Discovery Drug Resistance, Multiple / drug effects Medizin Antitubercular agents Multidrug-resistant tuberculosis Chemotherapy |
| topic_facet | MEDICAL / Chemotherapy Tuberculosis, Multidrug-Resistant / drug therapy Drug Discovery Drug Resistance, Multiple / drug effects Medizin Antitubercular agents Multidrug-resistant tuberculosis Chemotherapy |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=346571 |
| work_keys_str_mv | AT vinsovajarmila developmentofnewmdrtuberculosisdrugs AT kratkymartin developmentofnewmdrtuberculosisdrugs |